Pasar al contenido principal

CARACTERIZACION GENOMICA DEL SINDROME DE LYNCH MEDIANTE SECUENCIACION DE NUEVA GENERACION (NGS): CORRELACION CON EL PERFIL TRANSCRIPTOMICO Y EPIGENOMICO

SAF2010-19273

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2010
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Subdirección General de Proyectos de Investigación
Centro beneficiario FUNDACIÓ DE RECERCA CLÍNIC BARCELONA-INSTITUT D'INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12

  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Cazier, Jean-Baptiste|||0000-0001-7581-9051
  • Tomlinson, Ian P. M.
  • Carvajal-Carmona, Luis G.|||0000-0001-7129-2918
  • Palles, Claire|||0000-0002-9670-2263
  • Lamas, Maria J.|||0000-0001-8875-3290
  • Baiget Bastús, Montserrat
  • Lopez-Fernandez, Luis A.|||0000-0003-3964-5837
  • Brea-Fernández, Alejandro|||0000-0003-1527-471X
  • Abulí, Anna|||0000-0001-9894-0639
  • Bujanda, Luis|||0000-0002-4353-9968
  • Clofent, Juan
  • Gonzalez, Dolors
  • Xicola, Rosa
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Jover, Rodrigo
  • Llor, Xavier|||0000-0002-6259-185X
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Castells, Antoni|||0000-0001-8431-2033
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Ruiz-Ponte, Clara|||0000-0002-2200-0162
Background: Colorectal cancer (CRC) is a disease of complex aetiology, with much of the expected inherited risk being due to several common low risk variants. Genome-Wide Association Studies (GWAS) have identified 20 CRC risk variants. Nevertheless, these have only been able to explain part of the missing heritability. Moreover, these signals have only been inspected in populations of Northern European origin.Results: Thus, we followed the same approach in a Spanish cohort of 881 cases and 667 controls. Sixty-four variants at 24 loci were found to be associated with CRC at p-values <10-5. We therefore evaluated the 24 loci in another Spanish replication cohort (1481 cases and 1850 controls). Two of these SNPs, rs12080929 at 1p33 (P=0.042; P=5.523x10; OR (CI95%)=0.866(0.782-0.959)) and rs11987193 at 8p12 (P=0.039; P=6.985x10; OR (CI95%)=0.786(0.705-0.878)) were replicated in the second Phase, although they did not reach genome-wide statistical significance.Conclusions: We have performed the first CRC GWAS in a Southern European population and by these means we were able to identify two new susceptibility variants at 1p33 and 8p12 loci. These two SNPs are located near the SLC5A9 and DUSP4 loci, respectively, which could be good functional candidates for the association signals. We therefore believe that these two markers constitute good candidates for CRC susceptibility loci and should be further evaluated in other larger datasets. Moreover, we highlight that were these two SNPs true susceptibility variants, they would constitute a decrease in the CRC missing heritability fraction. © 2013 Fernández-Rozadilla et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, Simone
  • Lorenzo Bermejo, Justo|||0000-0002-6568-5333
  • Chang-Claude, Jenny
  • Hoffmeister, Michael
  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Castells, Antoni|||0000-0001-8431-2033
  • Piñol, Virgínia
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Gonzalo, Victoria|||0000-0003-4611-5463
  • Ocaña, Teresa
  • Serradesanferm, Anna
  • Moreira, Leticia
  • Cuatrecasas, Miriam|||0000-0003-3063-0110
  • Piqué, Josep, M.
  • Ángel, L.
  • Javier, A.
  • Javier, O.
  • Cubiella, Joaquín|||0000-0002-9994-4831
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Abulí, Anna|||0000-0001-9894-0639
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • Iglesias, Mar|||0000-0002-2274-4671
  • Seoane, Agustín|||0000-0001-8023-4445
  • Bory, Felipe
  • Navarro Rubio, Gemma|||0000-0002-7195-9046
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Dedeu, Josep Maria|||0000-0003-0522-1032
  • Cristina, A.
  • Puigvehí, Marc|||0000-0002-3694-3241
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, D.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Cuquerella, Jaime
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Vicent, H.
  • Llor, Xavier|||0000-0002-6259-185X
  • Xicola, Rosa M.|||0000-0001-6466-1885
  • Piñol Pascual, Marta
  • Rosinach, Mercè
  • Roca, Anna
  • Pons, Elisenda
  • Hernández, José
  • Gassull Durò, Miquel Àngel|||0000-0001-7751-4833
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, Esther|||0000-0002-2777-0000
  • Montserrat, F.
  • Maria, E.
  • Reñé, Josep Maria
  • Piñol, Carmen
  • Buenestado, Juan
  • Viñas, Joan
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • González, Dolors
  • Roman, Eva|||0000-0001-9084-8555
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Concepción, Mar|||0000-0003-1821-0359
  • Martín Flix, Marta|||0000-0001-7849-3616
  • Pétriz, Lourdes
  • Daniel, M.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth-Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz-Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, Henry|||0000-0001-7003-399X
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts. © 2013 Picelli et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Case-control study for colorectal cancer genetic susceptibility in EPICOLON, Previously identified variants and mucins

  • Abulí, Anna|||0000-0001-9894-0639
  • Fernández-Rozadilla, Ceres|||0000-0001-7330-4804
  • Alonso-Espinaco, Virginia|||0000-0003-1174-1579
  • Muñoz, Jenifer
  • Gonzalo, Victoria|||0000-0003-4611-5463
  • Bessa Caserras, Xavier|||0000-0003-4680-1228
  • González, Dolors
  • Clofent, Joan
  • Cubiella, Joaquín|||0000-0002-9994-4831
  • Morillas, Juan D.
  • Rigau, Joaquim
  • Latorre, Mercedes
  • Fernández-Bañares, Fernando|||0000-0002-1489-504X
  • Peña, Elena
  • Riestra, Sabino|||0000-0002-9383-3698
  • Payá, Artemio
  • Jover, Rodrigo
  • Xicola, Rosa M.|||0000-0001-6466-1885
  • Llor, Xavier|||0000-0002-6259-185X
  • Carvajal-Carmona, Luis
  • Villanueva, Cristina|||0000-0002-0783-1259
  • Moreno Aguado, Victor Raul|||0000-0002-2818-5487
  • Piqué, Josep Mª|||0000-0002-3157-4950
  • Carracedo, Ángel|||0000-0003-1085-8986
  • Castells, Antoni|||0000-0001-8431-2033
  • Andreu, Montserrat|||0000-0003-4286-1098
  • Ruiz-Ponte, Clara|||0000-0002-2200-0162
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Roman, Eva|||0000-0001-9084-8555
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Poca Sans, Maria|||0000-0002-0235-1395
  • Concepción, Mar|||0000-0003-1821-0359
  • Martín Flix, Marta|||0000-0001-7849-3616
Background: Colorectal cancer (CRC) is the second leading cause of cancer death in developed countries. Familial aggregation in CRC is also important outside syndromic forms and, in this case, a polygenic model with several common low-penetrance alleles contributing to CRC genetic predisposition could be hypothesized. Mucins and GALNTs (N-acetylgalactosaminyltransferase) are interesting candidates for CRC genetic susceptibility and have not been previously evaluated. We present results for ten genetic variants linked to CRC risk in previous studies (previously identified category) and 18 selected variants from the mucin gene family in a case-control association study from the Spanish EPICOLON consortium.Methods: CRC cases and matched controls were from EPICOLON, a prospective, multicenter, nationwide Spanish initiative, comprised of two independent stages. Stage 1 corresponded to 515 CRC cases and 515 controls, whereas stage 2 consisted of 901 CRC cases and 909 controls. Also, an independent cohort of 549 CRC cases and 599 controls outside EPICOLON was available for additional replication. Genotyping was performed for ten previously identified SNPs in ADH1C, APC, CCDN1, IL6, IL8, IRS1, MTHFR, PPARG, VDR and ARL11, and 18 selected variants in the mucin gene family.Results: None of the 28 SNPs analyzed in our study was found to be associated with CRC risk. Although four SNPs were significant with a P-value < 0.05 in EPICOLON stage 1 [rs698 in ADH1C (OR = 1.63, 95% CI = 1.06-2.50, P-value = 0.02, recessive), rs1800795 in IL6 (OR = 1.62, 95% CI = 1.10-2.37, P-value = 0.01, recessive), rs3803185 in ARL11 (OR = 1.58, 95% CI = 1.17-2.15, P-value = 0.007, codominant), and rs2102302 in GALNTL2 (OR = 1.20, 95% CI = 1.00-1.44, P-value = 0.04, log-additive 0, 1, 2 alleles], only rs3803185 achieved statistical significance in EPICOLON stage 2 (OR = 1.34, 95% CI = 1.06-1.69, P-value = 0.01, recessive). In the joint analysis for both stages, results were only significant for rs3803185 (OR = 1.12, 95% CI = 1.00-1.25, P-value = 0.04, log-additive 0, 1, 2 alleles) and borderline significant for rs698 and rs2102302. The rs3803185 variant was not significantly associated with CRC risk in an external cohort (MCC-Spain), but it still showed some borderline significance in the pooled analysis of both cohorts (OR = 1.08, 95% CI = 0.98-1.18, P-value = 0.09, log-additive 0, 1, 2 alleles).Conclusions: ARL11, ADH1C, GALNTL2 and IL6 genetic variants may have an effect on CRC risk. Further validation and meta-analyses should be undertaken in larger CRC studies. © 2011 Abulí et al; licensee BioMed Central Ltd.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer

  • Esteban-Jurado, Clara
  • Abulí, Anna
  • Bessa i Caserras, Xavier
  • Andreu García, Montserrat
  • Castellví Bel, Sergi
Purpose. Colorectal cancer is an important cause of mortality in the developed world. Hereditary forms are due to germ-line mutations in APC, MUTYH, and the mismatch repair genes, but many cases present familial aggregation but an unknown inherited cause. The hypothesis of rare high-penetrance mutations in new genes is a likely explanation for the underlying predisposition in some of these familial cases. Methods. Exome sequencing was performed in 43 patients with colorectal cancer from 29 families with strong disease aggregation without mutations in known hereditary colorectal cancer genes. Data analysis selected only very rare variants (0–0.1%), producing a putative loss of function and located in genes with a role compatible with cancer. Variants in genes previously involved in hereditary colorectal cancer or nearby previous colorectal cancer genome-wide association study hits were also chosen. Results. Twenty-eight final candidate variants were selected and validated by Sanger sequencing. Correct family segregation and somatic studies were used to categorize the most interesting variants in CDKN1B, XRCC4, EPHX1, NFKBIZ, SMARCA4, and BARD1. Conclusion. We identified new potential colorectal cancer predisposition variants in genes that have a role in cancer predisposition and are involved in DNA repair and the cell cycle, which supports their putative involvement in germ-line predisposition to this neoplasm., We are sincerely grateful to the Centre Nacional d'Anàlisi Genòmica and the Biobank of Hospital Clínic–IDIBAPS, Barcelona, for technical help, and the International Cancer Genome Consortium for access to exome data set. The work was carried out (in part) at the Esther Koplowitz Centre, Barcelona. CEJ and JM are supported by a contract from CIBERehd. MVC is supported by Ministerio de Educación, Cultura y Deporte (FPU12/05138). PG and SCB are supported by a contract from the Fondo de Investigación Sanitaria (JR13/00013 and CP 03-0070, respectively). CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (10/00641, 11/00219, 11/00681, RD12/0036/006, 13/02588), the Ministerio de Economía y Competitividad (SAF2010-19273), Fundación Científica de la Asociación Española contra el Cáncer (GCB13131592CAST), COST Action BM1206 (SCB and CRP), Beca Grupo de Trabajo “Oncología” AEG (Asociación Española de Gastroenterología), and Agència de Gestió d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya, 2014SGR255).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

New genes emerging for colorectal cancer predisposition

  • Esteban Jurado, Clara
  • Garre, Pilar
  • Vila, Maria
  • Lozano, Juan José
  • Pristoupilova, Anna
  • Beltrán, Sergi
  • Abulí, Anna
  • Muñoz, Jenifer
  • Balaguer Prunés, Francesc
  • Ocaña, Teresa
  • Castells, Antoni
  • Piqué, Josep M.
  • Carracedo, Ángel
  • Ruiz Ponte, Clara
  • Bessa i Caserras, Xavier
  • Andreu García, Montserrat
  • Bujanda, Luis
  • Caldés, Trinidad
  • Castellví Bel, Sergi
Colorectal cancer (CRC) is one of the most frequent neoplasms and an important cause of mortality in the developed world. This cancer is caused by both genetic and environmental factors although 35% of the variation in CRC susceptibility involves inherited genetic differences. Mendelian syndromes account for about 5% of the total burden of CRC, with Lynch syndrome and familial adenomatous polyposis the most common forms. Excluding hereditary forms, there is an important fraction of CRC cases that present familial aggregation for the disease with an unknown germline genetic cause. CRC can be also considered as a complex disease taking into account the common disease-commom variant hypothesis with a polygenic model of inheritance where the genetic components of common complex diseases correspond mostly to variants of low/moderate effect. So far, 30 common, low-penetrance susceptibility variants have been identified for CRC. Recently, new sequencing technologies including exome- and whole-genome sequencing have permitted to add a new approach to facilitate the identification of new genes responsible for human disease predisposition. By using whole-genome sequencing, germline mutations in the POLE and POLD1 genes have been found to be responsible for a new form of CRC genetic predisposition called polymerase proofreading-associated polyposis., Supported by SCB is supported by a contract from the Fondo de Investigación Sanitaria, No. CP 03-0070; CEJ and JM are supported by a contract from CIBERehd; CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III; Fondo de Investigación Sanitaria/FEDER, No.11/00219 and No. 11/00681, Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia, No. 07PXIB9101209PR, Ministerio de Ciencia e Innovación, No. SAF2010-19273, Asociación Española contra el Cáncer (Fundación Científica GCB13131592CAST y Junta de Barcelona), Fundació Olga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and ACar), and COST Action BM1206 (SCB and CRP).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals

  • Abulí, Anna
  • Andreu Camps, Montserrat
  • Castellví Bel, Sergi
Colorectal cancer is one of the most frequent neoplasms and an important cause of mortality in the developed world. Mendelian syndromes account for about 5% of the total burden of CRC, being Lynch syndrome and familial adenomatous polyposis the most common forms. Lynch syndrome tumors develop mainly as a consequence of defective DNA mismatch repair associated with germline mutations in MLH1, MSH2, MSH6 and PMS2. A significant proportion of variants identified by screening these genes correspond to missense or noncoding changes without a clear pathogenic consequence, and they are designated as “variants of uncertain significance”, being the c.1852_1853delinsGC (p.K618A) variant in the MLH1 gene a clear example. The implication of this variant as a low-penetrance risk variant for CRC was assessed in the present study by performing a case-control study within a large cohort from the COGENT consortium-COST Action BM1206 including 18,723 individuals (8,055 colorectal cancer cases and 10,668 controls) and a case-only genotype-phenotype correlation with several clinical and pathological characteristics restricted to the Epicolon cohort. Our results showed no involvement of this variant as a low-penetrance variant for colorectal cancer genetic susceptibility and no association with any clinical and pathological characteristics including family history for this neoplasm or Lynch syndrome., This work was supported by COST Action BM1206. Groups 1, 4, 5, 6, 7, 8, 10 and 13 are active members of this consortium. Edinburgh: This work was supported by a Cancer Research UK Programme Grant (C348/A12076) and a Centre Grant from the CORE Charity. Epicolon: SCB is supported by a contract from the Fondo de Investigación Sanitaria (CP 03-0070). JM and CEJ are supported by contracts from the CIBERehd. CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (11/00219, 11/00681), Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovación (SAF2010-19273), Asociación Española contra el Cáncer (Fundación Científica GCB13131592CAST y Junta de Barcelona), Fundació Olga Torres (SCB and CRP) and FP7 CHIBCHA Consortium (SCB and ACar). Kiel: This work was supported by the German Ministry for Education and Research through the German National Genome Research Network (NGFNplus) Colon Cancer Network (CCN). Leiden: This work was supported by the Dutch Cancer Society with grant KWF-UL-2005-3247. Stockholm: The Swedish sample and data resource were funded by the Swedish Cancer Society, the Swedish Scientific Research Council and the Stockholm Cancer Foundation. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Association between CASP8 –652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study

  • Pardini, Barbara
  • Verderio, Paolo
  • Pizzamiglio, Sara
  • Nici, Carmela
  • Maiorana, Maria Valeria
  • Naccarati, Alessio
  • Vodickova, Ludmila
  • Vymetalkova, Veronika
  • Veneroni, Silvia
  • Daidone, Maria Grazia
  • Ravagnani, Fernando
  • Bianchi, Tiziana
  • Bujanda, Luis
  • Carracedo, Angel
  • Castells, Antoni
  • Ruiz-Ponte, Clara
  • Morreau, Hans
  • Howarth, Kimberley
  • Jones, Angela
  • Castellví-Bel, Sergi
  • Li, Li
  • Tomlinson, Ian
  • Van Wezel, Tom
  • Vodicka, Pavel
  • Radice, Paolo
  • Peterlongo, Paolo
Members of the EPICOLON Consortium (Gastrointestinal Oncology Group of the Spanish Gastroenterological Association) are: Hospital 12 de Octubre, Madrid: Juan Diego Morillas (local coordinator), Raquel Muñoz, Marisa Manzano, Francisco Colina, Jose Díaz, Carolina Ibarrola, Guadalupe López, Alberto Ibáñez; Hospital Clínic, Barcelona: Antoni Castells (local coordinator), Virgínia Piñol, Sergi Castellví-Bel, Francesc Balaguer, Victoria Gonzalo, Teresa Ocaña, María Dolores Giráldez, Maria Pellisé, Anna Serradesanferm, Leticia Moreira, Miriam Cuatrecasas, Josep M. Piqué; Hospital Clínico Universitario, Zaragoza: Ángel Lanas (local coordinator), Javier Alcedo, Javier Ortego; Hospital Cristal-Piñor, Complexo Hospitalario de Ourense: Joaquin Cubiella (local coordinator), Ma Soledad Díez, Mercedes Salgado, Eloy Sánchez, Mariano Vega; Parc de Salut Mar, Barcelona: Montserrat Andreu (local coordinator), Anna Abuli, Xavier Bessa, Mar Iglesias, Agustín Seoane, Felipe Bory, Gemma Navarro, Beatriz Bellosillo; Josep Ma Dedeu, Cristina Álvarez, Marc Puigvehí; Hospital San Eloy, Baracaldo and Hospital Donostia, CIBERehd, University of Basque Country, San Sebastián: Luis Bujanda (local coordinator) Ángel Cosme, Inés Gil, Mikel Larzabal, Carlos Placer, María del Mar Ramírez, Elisabeth Hijona, Jose M. Enríquez-Navascués, Jose L. Elosegui; Hospital General Universitario de Alicante: Artemio Payá (EPICOLON I local coordinator), Rodrigo Jover (EPICOLON II local coordinator), Cristina Alenda, Laura Sempere, Nuria Acame, Estefanía Rojas, Lucía Pérez-Carbonell; Hospital General de Granollers: Joaquim Rigau (local coordinator), Ángel Serrano, Anna Giménez; Hospital General de Vic: Joan Saló (local coordinator), Eduard Batiste-Alentorn, Josefina Autonell, Ramon Barniol; Hospital General Universitario de Guadalajara and Fundación para la Formación e Investigación Sanitarias Murcia: Ana María García (local coordinator), Fernando Carballo, Antonio Bienvenido, Eduardo Sanz, Fernando González, Jaime Sánchez, Akiko Ono; Hospital General Universitario de Valencia: Mercedes Latorre (local coordinator), Enrique Medina, Jaime Cuquerella, Pilar Canelles, Miguel Martorell, José Ángel García, Francisco Quiles, Elisa Orti; CHUVI-Hospital Meixoeiro, Vigo: EPICOLON I: Juan Clofent (local coordinator), Jaime Seoane, Antoni Tardío, Eugenia Sanchez. EPICOLON II Ma Luisa de Castro (local coordinator), Antoni Tardío, Juan Clofent, Vicent Hernández; Hospital Universitari Germans Trias i Pujol, Badalona and Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, IL, USA: Xavier Llor (local coordinator), Rosa M. Xicola, Marta Piñol, Mercè Rosinach, Anna Roca, Elisenda Pons, José M. Hernández, Miquel A. Gassull; Hospital Universitari Mútua de Terrassa: Fernando Fernández-Bañares (local coordinator), Josep M. Viver, Antonio Salas, Jorge Espinós, Montserrat Forné, Maria Esteve; Hospital Universitari Arnau de Vilanova, Lleida: Josep M. Reñé (local coordinator), Carmen Piñol, Juan Buenestado, Joan Viñas; Hospital Universitario de Canarias: Enrique Quintero (local coordinator), David Nicolás, Adolfo Parra, Antonio Martín; Hospital Universitario La Fe, Valencia: Lidia Argüello (local coordinator), Vicente Pons, Virginia Pertejo, Teresa Sala; Hospital Sant Pau, Barcelona: Dolors Gonzalez (local coordinator) Eva Roman, Teresa Ramon, Maria Poca, Ma Mar Concepción, Marta Martin, Lourdes Pétriz; Hospital Xeral Cies, Vigo: Daniel Martinez (local coordinator); Fundacion Publica Galega de Medicina Xenomica (FPGMX), CIBERER, Genomic Medicine Group-University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain: Ángel Carracedo (local coordinator), Clara Ruiz-Ponte, Ceres Fernández-Rozadilla, Ma Magdalena Castro; Hospital Universitario Central de Asturias: Sabino Riestra (local coordinator), Luis Rodrigo; Hospital de Galdácano, Vizcaya: Javier Fernández (local coordinator), Jose Luis Cabriada; Fundación Hospital de Calahorra (La Rioja) La Rioja: Luis Carreño (local coordinator), Susana Oquiñena, Federico Bolado; Hospital Royo Villanova, Zaragoza: Elena Peña (local coordinator), José Manuel Blas, Gloria Ceña, Juan José Sebastián; Hospital Universitario Reina Sofía, Córdoba: Antonio Naranjo (local coordinator)., The common −652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant −652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69–0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians., For all cohorts: This work was supported by COST Action BM1206. Spanish cohort: SCB is supported by a contract from the Fondo de Investigación Sanitaria (CP 03-0070 to SCB). Networked Biomedical Research Centre for Hepatic and Digestive Diseases and Centro de Investigación Biomédica en Red de Enfermedades Raras are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (08/0024, 08/1276, PS09/02368, 11/00219, 11/00681), Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovación (SAF2010-19273), Asociación Española contra el Cáncer (Fundación Científica y Junta de Barcelona), Fundació Olga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and A. Carracedo). American cohort: Kentucky Colon Cancer Genetic Epidemiology Study is supported by National Institutes of Health grant R01CA136726 to LL. English cohort: Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). Czech cohort: Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286 and P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient). Dutch cohort: Dutch Cancer Society, grant KWF-UL-2010-4656.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype

  • Gonzalo, Victoria
  • Lozano, Juan Jose
  • Alonso-Espinaco, Virginia
  • Moreira, Leticia
  • Muñoz, Jenifer
  • Pellisé, Maria
  • Castellví-Bel, Sergi
  • Bessa, Xavier
  • Andreu, Montserrat
  • Xicola, Rosa M.
  • Llor, Xavier
  • Ruiz-Ponte, Clara
  • Carracedo, Angel
  • Jover, Rodrigo
  • Castells, Antoni
  • Balaguer, Francesc
The members of the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association are: Hospital 12 de Octubre, Madrid: Juan Diego Morillas (local coordinator), Raquel Muñoz, Marisa Manzano, Francisco Colina, Jose Díaz, Carolina Ibarrola, Guadalupe López, Alberto Ibáñez; Hospital Clínic, Barcelona: Antoni Castells (local coordinator), Virgínia Piñol, Sergi Castellví-Bel, Francesc Balaguer, Victoria Gonzalo, Teresa Ocaña, María Dolores Giráldez, Maria Pellisé, Anna Serradesanferm, Leticia Moreira, Miriam Cuatrecasas, Josep M. Piqué; Hospital Clínico Universitario, Zaragoza: Ángel Lanas (local coordinator), Javier Alcedo, Javier Ortego; Hospital Cristal-Piñor, Complexo Hospitalario de Ourense: Joaquin Cubiella (local coordinator), Ma Soledad Díez, Mercedes Salgado, Eloy Sánchez, Mariano Vega; Hospital del Mar, Barcelona: Montserrat Andreu (local coordinator), Anna Abuli, Xavier Bessa, Mar Iglesias, Agustín Seoane, Felipe Bory, Gemma Navarro, Beatriz Bellosillo, Josep Ma Dedeu, Cristina Álvarez, Begoña Gonzalez; Hospital San Eloy, Baracaldo and Hospital Donostia, CIBERehd, University of Country Basque, San Sebastián: Luis Bujanda (local coordinator) Ángel Cosme, Inés Gil, Mikel Larzabal, Carlos Placer, María del Mar Ramírez, Elisabeth Hijona, Jose M. Enríquez-Navascués, Jose L. Elosegui; Hospital General Universitario de Alicante: Artemio Payá (EPICOLON I local coordinator), Rodrigo Jover (EPICOLON II local coordinator), Cristina Alenda, Laura Sempere, Nuria Acame, Estefanía Rojas, Lucía Pérez-Carbonell; Hospital General de Granollers: Joaquim Rigau (local coordinator), Ángel Serrano, Anna Giménez; Hospital General de Vic: Joan Saló (local coordinator), Eduard Batiste-Alentorn, Josefina Autonell, Ramon Barniol; Hospital General Universitario de Guadalajara and Fundación para la Formación e Investigación Sanitarias Murcia: Ana María García (local coordinator), Fernando Carballo, Antonio Bienvenido, Eduardo Sanz, Fernando González, Jaime Sánchez, Akiko Ono; Hospital General Universitario de Valencia: Mercedes Latorre (local coordinator), Enrique Medina, Jaime Cuquerella, Pilar Canelles, Miguel Martorell, José Ángel García, Francisco Quiles, Elisa Orti; CHUVI-Hospital Meixoeiro, Vigo: EPICOLON I: Juan Clofent (local coordinator), Jaime Seoane, Antoni Tardío, Eugenia Sanchez; EPICOLON II: Ma Luisa de Castro (local coordinator), Antoni Tardío, Juan Clofent, Vicent Hernández; Hospital Universitari Germans Trias i Pujol, Badalona and Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, IL: Xavier Llor (local coordinator), Rosa M. Xicola, Marta Piñol, Mercè Rosinach, Anna Roca, Elisenda Pons, José M. Hernández, Miquel A. Gassull; Hospital Universitari Mútua de Terrassa: Fernando Fernández-Bañares (local coordinator), Josep M. Viver, Antonio Salas, Jorge Espinós, Montserrat Forné, Maria Esteve; Hospital Universitari Arnau de Vilanova, Lleida: Josep M. Reñé (local coordinator), Carmen Piñol, Juan Buenestado, Joan Viñas; Hospital Universitario de Canarias: Enrique Quintero (local coordinator), David Nicolás, Adolfo Parra, Antonio Martín; Hospital Universitario La Fe, Valencia: Lidia Argüello (local coordinator), Vicente Pons, Virginia Pertejo, Teresa Sala; Hospital Sant Pau, Barcelona: Dolors Gonzalez (local coordinator), Eva Roman, Teresa Ramon, Maria Poca, Ma Mar Concepción, Marta Martin, Lourdes Pétriz; Hospital Xeral Cies, Vigo: Daniel Martinez (local coordinator); Fundacion Publica Galega de Medicina Xenomica (FPGMX), CIBERER, Genomic Medicine Group-University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain: Ángel Carracedo (local coordinator), Clara Ruiz-Ponte, Ceres Fernández-Rozadilla, Ma Magdalena Castro; Hospital Universitario Central de Asturias: Sabino Riestra (local coordinator), Luis Rodrigo; Hospital de Galdácano, Vizcaya: Javier Fernández (local coordinator), Jose Luis Cabriada; Fundación Hospital de Calahorra (La Rioja) La Rioja: Luis Carreño (local coordinator), Susana Oquiñena, Federico Bolado; Hospital Royo Villanova, Zaragoza: Elena Peña (local coordinator), José Manuel Blas, Gloria Ceña, Juan José Sebastián; Hospital Universitario Reina Sofía, Córdoba: Antonio Naranjo (local coordinator)., Epigenetics are thought to play a major role in the carcinogenesis of multiple sporadic colorectal cancers (CRC). Previous studies have suggested concordant DNA hypermethylation between tumor pairs. However, only a few methylation markers have been analyzed. This study was aimed at describing the epigenetic signature of multiple CRC using a genome-scale DNA methylation profiling. We analyzed 12 patients with synchronous CRC and 29 age-, sex-, and tumor location-paired patients with solitary tumors from the EPICOLON II cohort. DNA methylation profiling was performed using the Illumina Infinium HM27 DNA methylation assay. The most significant results were validated by Methylight. Tumors samples were also analyzed for the CpG Island Methylator Phenotype (CIMP); KRAS and BRAF mutations and mismatch repair deficiency status. Functional annotation clustering was performed. We identified 102 CpG sites that showed significant DNA hypermethylation in multiple tumors with respect to the solitary counterparts (difference in β value ≥0.1). Methylight assays validated the results for 4 selected genes (p = 0.0002). Eight out of 12(66.6%) multiple tumors were classified as CIMP-high, as compared to 5 out of 29(17.2%) solitary tumors (p = 0.004). Interestingly, 76 out of the 102 (74.5%) hypermethylated CpG sites found in multiple tumors were also seen in CIMP-high tumors. Functional analysis of hypermethylated genes found in multiple tumors showed enrichment of genes involved in different tumorigenic functions. In conclusion, multiple CRC are associated with a distinct methylation phenotype, with a close association between tumor multiplicity and CIMP-high. Our results may be important to unravel the underlying mechanism of tumor multiplicity., This work was supported by grants from the Hospital Clínic of Barcelona (Josep Font grant), Ministerio de Economí­a y Competitividad (SAF 2007-64873 and SAF2010-19273), Fundación Científica de la Asociación Española contra el Cáncer, and Instituto de Salud Carlos III (PI10/00384). “Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Unión Europea. Una manera de hacer Europa”. CIBEREHD is funded by the Instituto de Salud Carlos III.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

  • Picelli, S.
  • Lorenzo Bermejo, J.
  • Chang Claude, J.
  • Hoffmeister, M.
  • Fernández Rozadilla, C.
  • Carracedo, A.
  • Castells, A.
  • Castellví Bel, S.
  • Juan, D.M.
  • Raquel, M.
  • Marisa, M.
  • Francisco, C.
  • Jose, D.
  • Carolina, I.
  • Guadalupe, L.
  • Alberto, I.
  • Antoni, C.
  • Virgínia, P.
  • Sergi, C.B.
  • Balaguer, F.
  • Victoria, G.
  • Teresa, O.
  • María Dolores, G.
  • Maria, P.
  • Anna, S.
  • Leticia, M.
  • Miriam, C.
  • Josep, M.P.
  • Lanas, A.
  • Alcedo, J.
  • Ortego, F.J.
  • Joaquin, C.
  • Ma, S.D.
  • Mercedes, S.
  • Eloy, S.
  • Mariano, V.
  • Montserrat, A.
  • Anna, A.
  • Xavier, B.
  • Mar, I.
  • Agustín, S.
  • Felipe, B.
  • Gemma, N.
  • Beatriz, B.
  • De Josep, M.
  • Cristina, Á.
  • Marc, P.
  • Luis, B.
  • Ángel, C.
  • Inés, G.
  • Mikel, L.
  • Carlos, P.
  • María, d.M.R.
  • Elisabeth, H.
  • Jose, M.E.N.
  • Jose, L.E.
  • Artemio, P.
  • Rodrigo, J.
  • Cristina, A.
  • Laura, S.
  • Nuria, A.
  • Estefanía, R.
  • Lucía, P.C.
  • Joaquim, R.
  • Ángel, S.
  • Anna, G.
  • Joan, S.
  • Eduard, B.A.
  • Josefina, A.
  • Ramon, B.
  • Ana, M.G.
  • Fernando, C.
  • Antonio, B.
  • Eduardo, S.
  • Fernando, G.
  • Jaime, S.
  • Akiko, O.
  • Mercedes, L.
  • Enrique, M.
  • Jaime, C.
  • Pilar, C.
  • Miguel, M.
  • José, A.G.
  • Francisco, Q.
  • Elisa, O.
  • Juan, C.
  • Jaime, S.
  • Antoni, T.
  • Eugenia, S.
  • de Ma, L.C.
  • Antoni, T.
  • Juan, C.
  • Vicent, H.
  • Xavier, L.
  • Rosa, M.X.
  • Marta, P.
  • Mercè, R.
  • Anna, R.
  • Elisenda, P.
  • José, M.H.
  • Miquel, A.G.
  • Fernando, F.B.
  • Josep, M.V.
  • Antonio, S.
  • Jorge, E.
  • Montserrat, F.
  • Maria, E.
  • Josep, M.R.
  • Carmen, P.
  • Juan, B.
  • Joan, V.
  • Enrique, Q.
  • David, N.
  • Adolfo, P.
  • Antonio, M.
  • Lidia, A.
  • Vicente, P.
  • Virginia, P.
  • Teresa, S.
  • Dolors, G.
  • Eva, R.
  • Teresa, R.
  • Maria, P.
  • Ma, M.C.
  • Marta, M.
  • Lourdes, P.
  • Daniel, M.
  • Ángel, C.
  • Clara, R.P.
  • Ceres, F.R.
  • Ma, M.C.
  • Sabino, R.
  • Luis, R.
  • Javier, F.
  • Jose, L.C.
  • Luis, C.
  • Susana, O.
  • Federico, B.
  • Elena, P.
  • José, M.B.
  • Gloria, C.
  • Juan, J.S.
  • Antonio, N.
  • Naccarati, A.
  • Pardini, B.
  • Vodickova, L.
  • Müller, H.
  • Talseth Palmer, B.A.
  • Stibbard, G.
  • Peterlongo, P.
  • Nici, C.
  • Veneroni, S.
  • Li, L.
  • Casey, G.
  • Tenesa, A.
  • Farrington, S.M.
  • Tomlinson, I.
  • Moreno, V.
  • van Wezel, T.
  • Wijnen, J.
  • Dunlop, M.
  • Radice, P.
  • Scott, R.J.
  • Vodicka, P.
  • Ruiz Ponte, C.
  • Brenner, H.
  • Buch, S.
  • Völzke, H.
  • Hampe, J.
  • Schafmayer, C.
  • Lindblom, A.
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of the 35% broad-sense heritability estimated by twin studies remains unexplained. Recently our group performed a case-control study for eight Single Nucleotide Polymorphisms (SNPs) in 4 CRC genes. The present investigation is a follow-up of that study. We have genotyped six SNPs that showed a positive association and carried out a meta-analysis based on eight additional studies comprising in total more than 8000 cases and 6000 controls. The estimated recessive odds ratio for one of the SNPs, rs3219489 (MUTYH Q338H), decreased from 1.52 in the original Swedish study, to 1.18 in the Swedish replication, and to 1.08 in the initial meta-analysis. Since the corresponding summary probability value was 0.06, we decided to retrieve additional information for this polymorphism. The incorporation of six further studies resulted in around 13000 cases and 13000 controls. The newly updated OR was 1.03. The results from the present large, multicenter study illustrate the possibility of decreasing effect sizes with increasing samples sizes. Phenotypic heterogeneity, differential environmental exposures, and population specific linkage disequilibrium patterns may explain the observed difference of genetic effects between Sweden and the other investigated cohorts.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer

  • Esteban-Jurado, Clara
  • Abulí, Anna
  • Bessa i Caserras, Xavier
  • Andreu García, Montserrat
  • Castellví Bel, Sergi
Purpose. Colorectal cancer is an important cause of mortality in the developed world. Hereditary forms are due to germ-line mutations in APC, MUTYH, and the mismatch repair genes, but many cases present familial aggregation but an unknown inherited cause. The hypothesis of rare high-penetrance mutations in new genes is a likely explanation for the underlying predisposition in some of these familial cases. Methods. Exome sequencing was performed in 43 patients with colorectal cancer from 29 families with strong disease aggregation without mutations in known hereditary colorectal cancer genes. Data analysis selected only very rare variants (0–0.1%), producing a putative loss of function and located in genes with a role compatible with cancer. Variants in genes previously involved in hereditary colorectal cancer or nearby previous colorectal cancer genome-wide association study hits were also chosen. Results. Twenty-eight final candidate variants were selected and validated by Sanger sequencing. Correct family segregation and somatic studies were used to categorize the most interesting variants in CDKN1B, XRCC4, EPHX1, NFKBIZ, SMARCA4, and BARD1. Conclusion. We identified new potential colorectal cancer predisposition variants in genes that have a role in cancer predisposition and are involved in DNA repair and the cell cycle, which supports their putative involvement in germ-line predisposition to this neoplasm., We are sincerely grateful to the Centre Nacional d'Anàlisi Genòmica and the Biobank of Hospital Clínic–IDIBAPS, Barcelona, for technical help, and the International Cancer Genome Consortium for access to exome data set. The work was carried out (in part) at the Esther Koplowitz Centre, Barcelona. CEJ and JM are supported by a contract from CIBERehd. MVC is supported by Ministerio de Educación, Cultura y Deporte (FPU12/05138). PG and SCB are supported by a contract from the Fondo de Investigación Sanitaria (JR13/00013 and CP 03-0070, respectively). CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (10/00641, 11/00219, 11/00681, RD12/0036/006, 13/02588), the Ministerio de Economía y Competitividad (SAF2010-19273), Fundación Científica de la Asociación Española contra el Cáncer (GCB13131592CAST), COST Action BM1206 (SCB and CRP), Beca Grupo de Trabajo “Oncología” AEG (Asociación Española de Gastroenterología), and Agència de Gestió d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya, 2014SGR255).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The MLH1 c.1852_1853delinsGC (p.K618A) variant in colorectal cancer: genetic association study in 18,723 individuals

  • Abulí, Anna
  • Andreu Camps, Montserrat
  • Castellví Bel, Sergi
Colorectal cancer is one of the most frequent neoplasms and an important cause of mortality in the developed world. Mendelian syndromes account for about 5% of the total burden of CRC, being Lynch syndrome and familial adenomatous polyposis the most common forms. Lynch syndrome tumors develop mainly as a consequence of defective DNA mismatch repair associated with germline mutations in MLH1, MSH2, MSH6 and PMS2. A significant proportion of variants identified by screening these genes correspond to missense or noncoding changes without a clear pathogenic consequence, and they are designated as “variants of uncertain significance”, being the c.1852_1853delinsGC (p.K618A) variant in the MLH1 gene a clear example. The implication of this variant as a low-penetrance risk variant for CRC was assessed in the present study by performing a case-control study within a large cohort from the COGENT consortium-COST Action BM1206 including 18,723 individuals (8,055 colorectal cancer cases and 10,668 controls) and a case-only genotype-phenotype correlation with several clinical and pathological characteristics restricted to the Epicolon cohort. Our results showed no involvement of this variant as a low-penetrance variant for colorectal cancer genetic susceptibility and no association with any clinical and pathological characteristics including family history for this neoplasm or Lynch syndrome., This work was supported by COST Action BM1206. Groups 1, 4, 5, 6, 7, 8, 10 and 13 are active members of this consortium. Edinburgh: This work was supported by a Cancer Research UK Programme Grant (C348/A12076) and a Centre Grant from the CORE Charity. Epicolon: SCB is supported by a contract from the Fondo de Investigación Sanitaria (CP 03-0070). JM and CEJ are supported by contracts from the CIBERehd. CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (11/00219, 11/00681), Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovación (SAF2010-19273), Asociación Española contra el Cáncer (Fundación Científica GCB13131592CAST y Junta de Barcelona), Fundació Olga Torres (SCB and CRP) and FP7 CHIBCHA Consortium (SCB and ACar). Kiel: This work was supported by the German Ministry for Education and Research through the German National Genome Research Network (NGFNplus) Colon Cancer Network (CCN). Leiden: This work was supported by the Dutch Cancer Society with grant KWF-UL-2005-3247. Stockholm: The Swedish sample and data resource were funded by the Swedish Cancer Society, the Swedish Scientific Research Council and the Stockholm Cancer Foundation. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Multiple Sporadic Colorectal Cancers Display a Unique Methylation Phenotype

  • Gonzalo, Victoria
  • Lozano, Juan Jose
  • Alonso-Espinaco, Virginia
  • Moreira, Leticia
  • Muñoz, Jenifer
  • Pellisé, Maria
  • Castellví-Bel, Sergi
  • Bessa, Xavier
  • Andreu, Montserrat
  • Xicola, Rosa M.
  • Llor, Xavier
  • Ruiz-Ponte, Clara
  • Carracedo, Angel
  • Jover, Rodrigo
  • Castells, Antoni
  • Balaguer, Francesc
The members of the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association are: Hospital 12 de Octubre, Madrid: Juan Diego Morillas (local coordinator), Raquel Muñoz, Marisa Manzano, Francisco Colina, Jose Díaz, Carolina Ibarrola, Guadalupe López, Alberto Ibáñez; Hospital Clínic, Barcelona: Antoni Castells (local coordinator), Virgínia Piñol, Sergi Castellví-Bel, Francesc Balaguer, Victoria Gonzalo, Teresa Ocaña, María Dolores Giráldez, Maria Pellisé, Anna Serradesanferm, Leticia Moreira, Miriam Cuatrecasas, Josep M. Piqué; Hospital Clínico Universitario, Zaragoza: Ángel Lanas (local coordinator), Javier Alcedo, Javier Ortego; Hospital Cristal-Piñor, Complexo Hospitalario de Ourense: Joaquin Cubiella (local coordinator), Ma Soledad Díez, Mercedes Salgado, Eloy Sánchez, Mariano Vega; Hospital del Mar, Barcelona: Montserrat Andreu (local coordinator), Anna Abuli, Xavier Bessa, Mar Iglesias, Agustín Seoane, Felipe Bory, Gemma Navarro, Beatriz Bellosillo, Josep Ma Dedeu, Cristina Álvarez, Begoña Gonzalez; Hospital San Eloy, Baracaldo and Hospital Donostia, CIBERehd, University of Country Basque, San Sebastián: Luis Bujanda (local coordinator) Ángel Cosme, Inés Gil, Mikel Larzabal, Carlos Placer, María del Mar Ramírez, Elisabeth Hijona, Jose M. Enríquez-Navascués, Jose L. Elosegui; Hospital General Universitario de Alicante: Artemio Payá (EPICOLON I local coordinator), Rodrigo Jover (EPICOLON II local coordinator), Cristina Alenda, Laura Sempere, Nuria Acame, Estefanía Rojas, Lucía Pérez-Carbonell; Hospital General de Granollers: Joaquim Rigau (local coordinator), Ángel Serrano, Anna Giménez; Hospital General de Vic: Joan Saló (local coordinator), Eduard Batiste-Alentorn, Josefina Autonell, Ramon Barniol; Hospital General Universitario de Guadalajara and Fundación para la Formación e Investigación Sanitarias Murcia: Ana María García (local coordinator), Fernando Carballo, Antonio Bienvenido, Eduardo Sanz, Fernando González, Jaime Sánchez, Akiko Ono; Hospital General Universitario de Valencia: Mercedes Latorre (local coordinator), Enrique Medina, Jaime Cuquerella, Pilar Canelles, Miguel Martorell, José Ángel García, Francisco Quiles, Elisa Orti; CHUVI-Hospital Meixoeiro, Vigo: EPICOLON I: Juan Clofent (local coordinator), Jaime Seoane, Antoni Tardío, Eugenia Sanchez; EPICOLON II: Ma Luisa de Castro (local coordinator), Antoni Tardío, Juan Clofent, Vicent Hernández; Hospital Universitari Germans Trias i Pujol, Badalona and Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, Chicago, IL: Xavier Llor (local coordinator), Rosa M. Xicola, Marta Piñol, Mercè Rosinach, Anna Roca, Elisenda Pons, José M. Hernández, Miquel A. Gassull; Hospital Universitari Mútua de Terrassa: Fernando Fernández-Bañares (local coordinator), Josep M. Viver, Antonio Salas, Jorge Espinós, Montserrat Forné, Maria Esteve; Hospital Universitari Arnau de Vilanova, Lleida: Josep M. Reñé (local coordinator), Carmen Piñol, Juan Buenestado, Joan Viñas; Hospital Universitario de Canarias: Enrique Quintero (local coordinator), David Nicolás, Adolfo Parra, Antonio Martín; Hospital Universitario La Fe, Valencia: Lidia Argüello (local coordinator), Vicente Pons, Virginia Pertejo, Teresa Sala; Hospital Sant Pau, Barcelona: Dolors Gonzalez (local coordinator), Eva Roman, Teresa Ramon, Maria Poca, Ma Mar Concepción, Marta Martin, Lourdes Pétriz; Hospital Xeral Cies, Vigo: Daniel Martinez (local coordinator); Fundacion Publica Galega de Medicina Xenomica (FPGMX), CIBERER, Genomic Medicine Group-University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain: Ángel Carracedo (local coordinator), Clara Ruiz-Ponte, Ceres Fernández-Rozadilla, Ma Magdalena Castro; Hospital Universitario Central de Asturias: Sabino Riestra (local coordinator), Luis Rodrigo; Hospital de Galdácano, Vizcaya: Javier Fernández (local coordinator), Jose Luis Cabriada; Fundación Hospital de Calahorra (La Rioja) La Rioja: Luis Carreño (local coordinator), Susana Oquiñena, Federico Bolado; Hospital Royo Villanova, Zaragoza: Elena Peña (local coordinator), José Manuel Blas, Gloria Ceña, Juan José Sebastián; Hospital Universitario Reina Sofía, Córdoba: Antonio Naranjo (local coordinator)., Epigenetics are thought to play a major role in the carcinogenesis of multiple sporadic colorectal cancers (CRC). Previous studies have suggested concordant DNA hypermethylation between tumor pairs. However, only a few methylation markers have been analyzed. This study was aimed at describing the epigenetic signature of multiple CRC using a genome-scale DNA methylation profiling. We analyzed 12 patients with synchronous CRC and 29 age-, sex-, and tumor location-paired patients with solitary tumors from the EPICOLON II cohort. DNA methylation profiling was performed using the Illumina Infinium HM27 DNA methylation assay. The most significant results were validated by Methylight. Tumors samples were also analyzed for the CpG Island Methylator Phenotype (CIMP); KRAS and BRAF mutations and mismatch repair deficiency status. Functional annotation clustering was performed. We identified 102 CpG sites that showed significant DNA hypermethylation in multiple tumors with respect to the solitary counterparts (difference in β value ≥0.1). Methylight assays validated the results for 4 selected genes (p = 0.0002). Eight out of 12(66.6%) multiple tumors were classified as CIMP-high, as compared to 5 out of 29(17.2%) solitary tumors (p = 0.004). Interestingly, 76 out of the 102 (74.5%) hypermethylated CpG sites found in multiple tumors were also seen in CIMP-high tumors. Functional analysis of hypermethylated genes found in multiple tumors showed enrichment of genes involved in different tumorigenic functions. In conclusion, multiple CRC are associated with a distinct methylation phenotype, with a close association between tumor multiplicity and CIMP-high. Our results may be important to unravel the underlying mechanism of tumor multiplicity., This work was supported by grants from the Hospital Clínic of Barcelona (Josep Font grant), Ministerio de Economí­a y Competitividad (SAF 2007-64873 and SAF2010-19273), Fundación Científica de la Asociación Española contra el Cáncer, and Instituto de Salud Carlos III (PI10/00384). “Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Unión Europea. Una manera de hacer Europa”. CIBEREHD is funded by the Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

New genes emerging for colorectal cancer predisposition

  • Esteban Jurado, Clara
  • Garre, Pilar
  • Vila, Maria
  • Lozano, Juan José
  • Pristoupilova, Anna
  • Beltrán, Sergi
  • Abulí, Anna
  • Muñoz, Jenifer
  • Balaguer Prunés, Francesc
  • Ocaña, Teresa
  • Castells, Antoni
  • Piqué, Josep M.
  • Carracedo, Ángel
  • Ruiz Ponte, Clara
  • Bessa i Caserras, Xavier
  • Andreu García, Montserrat
  • Bujanda, Luis
  • Caldés, Trinidad
  • Castellví Bel, Sergi
Colorectal cancer (CRC) is one of the most frequent neoplasms and an important cause of mortality in the developed world. This cancer is caused by both genetic and environmental factors although 35% of the variation in CRC susceptibility involves inherited genetic differences. Mendelian syndromes account for about 5% of the total burden of CRC, with Lynch syndrome and familial adenomatous polyposis the most common forms. Excluding hereditary forms, there is an important fraction of CRC cases that present familial aggregation for the disease with an unknown germline genetic cause. CRC can be also considered as a complex disease taking into account the common disease-commom variant hypothesis with a polygenic model of inheritance where the genetic components of common complex diseases correspond mostly to variants of low/moderate effect. So far, 30 common, low-penetrance susceptibility variants have been identified for CRC. Recently, new sequencing technologies including exome- and whole-genome sequencing have permitted to add a new approach to facilitate the identification of new genes responsible for human disease predisposition. By using whole-genome sequencing, germline mutations in the POLE and POLD1 genes have been found to be responsible for a new form of CRC genetic predisposition called polymerase proofreading-associated polyposis., Supported by SCB is supported by a contract from the Fondo de Investigación Sanitaria, No. CP 03-0070; CEJ and JM are supported by a contract from CIBERehd; CIBERehd and CIBERER are funded by the Instituto de Salud Carlos III; Fondo de Investigación Sanitaria/FEDER, No.11/00219 and No. 11/00681, Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia, No. 07PXIB9101209PR, Ministerio de Ciencia e Innovación, No. SAF2010-19273, Asociación Española contra el Cáncer (Fundación Científica GCB13131592CAST y Junta de Barcelona), Fundació Olga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and ACar), and COST Action BM1206 (SCB and CRP).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association between CASP8 –652 6N Del Polymorphism (rs3834129) and Colorectal Cancer Risk: Results from a Multi-Centric Study

  • Pardini, Barbara
  • Verderio, Paolo
  • Pizzamiglio, Sara
  • Nici, Carmela
  • Maiorana, Maria Valeria
  • Naccarati, Alessio
  • Vodickova, Ludmila
  • Vymetalkova, Veronika
  • Veneroni, Silvia
  • Daidone, Maria Grazia
  • Ravagnani, Fernando
  • Bianchi, Tiziana
  • Bujanda, Luis
  • Carracedo, Angel
  • Castells, Antoni
  • Ruiz-Ponte, Clara
  • Morreau, Hans
  • Howarth, Kimberley
  • Jones, Angela
  • Castellví-Bel, Sergi
  • Li, Li
  • Tomlinson, Ian
  • Van Wezel, Tom
  • Vodicka, Pavel
  • Radice, Paolo
  • Peterlongo, Paolo
Members of the EPICOLON Consortium (Gastrointestinal Oncology Group of the Spanish Gastroenterological Association) are: Hospital 12 de Octubre, Madrid: Juan Diego Morillas (local coordinator), Raquel Muñoz, Marisa Manzano, Francisco Colina, Jose Díaz, Carolina Ibarrola, Guadalupe López, Alberto Ibáñez; Hospital Clínic, Barcelona: Antoni Castells (local coordinator), Virgínia Piñol, Sergi Castellví-Bel, Francesc Balaguer, Victoria Gonzalo, Teresa Ocaña, María Dolores Giráldez, Maria Pellisé, Anna Serradesanferm, Leticia Moreira, Miriam Cuatrecasas, Josep M. Piqué; Hospital Clínico Universitario, Zaragoza: Ángel Lanas (local coordinator), Javier Alcedo, Javier Ortego; Hospital Cristal-Piñor, Complexo Hospitalario de Ourense: Joaquin Cubiella (local coordinator), Ma Soledad Díez, Mercedes Salgado, Eloy Sánchez, Mariano Vega; Parc de Salut Mar, Barcelona: Montserrat Andreu (local coordinator), Anna Abuli, Xavier Bessa, Mar Iglesias, Agustín Seoane, Felipe Bory, Gemma Navarro, Beatriz Bellosillo; Josep Ma Dedeu, Cristina Álvarez, Marc Puigvehí; Hospital San Eloy, Baracaldo and Hospital Donostia, CIBERehd, University of Basque Country, San Sebastián: Luis Bujanda (local coordinator) Ángel Cosme, Inés Gil, Mikel Larzabal, Carlos Placer, María del Mar Ramírez, Elisabeth Hijona, Jose M. Enríquez-Navascués, Jose L. Elosegui; Hospital General Universitario de Alicante: Artemio Payá (EPICOLON I local coordinator), Rodrigo Jover (EPICOLON II local coordinator), Cristina Alenda, Laura Sempere, Nuria Acame, Estefanía Rojas, Lucía Pérez-Carbonell; Hospital General de Granollers: Joaquim Rigau (local coordinator), Ángel Serrano, Anna Giménez; Hospital General de Vic: Joan Saló (local coordinator), Eduard Batiste-Alentorn, Josefina Autonell, Ramon Barniol; Hospital General Universitario de Guadalajara and Fundación para la Formación e Investigación Sanitarias Murcia: Ana María García (local coordinator), Fernando Carballo, Antonio Bienvenido, Eduardo Sanz, Fernando González, Jaime Sánchez, Akiko Ono; Hospital General Universitario de Valencia: Mercedes Latorre (local coordinator), Enrique Medina, Jaime Cuquerella, Pilar Canelles, Miguel Martorell, José Ángel García, Francisco Quiles, Elisa Orti; CHUVI-Hospital Meixoeiro, Vigo: EPICOLON I: Juan Clofent (local coordinator), Jaime Seoane, Antoni Tardío, Eugenia Sanchez. EPICOLON II Ma Luisa de Castro (local coordinator), Antoni Tardío, Juan Clofent, Vicent Hernández; Hospital Universitari Germans Trias i Pujol, Badalona and Section of Digestive Diseases and Nutrition, University of Illinois at Chicago, IL, USA: Xavier Llor (local coordinator), Rosa M. Xicola, Marta Piñol, Mercè Rosinach, Anna Roca, Elisenda Pons, José M. Hernández, Miquel A. Gassull; Hospital Universitari Mútua de Terrassa: Fernando Fernández-Bañares (local coordinator), Josep M. Viver, Antonio Salas, Jorge Espinós, Montserrat Forné, Maria Esteve; Hospital Universitari Arnau de Vilanova, Lleida: Josep M. Reñé (local coordinator), Carmen Piñol, Juan Buenestado, Joan Viñas; Hospital Universitario de Canarias: Enrique Quintero (local coordinator), David Nicolás, Adolfo Parra, Antonio Martín; Hospital Universitario La Fe, Valencia: Lidia Argüello (local coordinator), Vicente Pons, Virginia Pertejo, Teresa Sala; Hospital Sant Pau, Barcelona: Dolors Gonzalez (local coordinator) Eva Roman, Teresa Ramon, Maria Poca, Ma Mar Concepción, Marta Martin, Lourdes Pétriz; Hospital Xeral Cies, Vigo: Daniel Martinez (local coordinator); Fundacion Publica Galega de Medicina Xenomica (FPGMX), CIBERER, Genomic Medicine Group-University of Santiago de Compostela, Santiago de Compostela, Galicia, Spain: Ángel Carracedo (local coordinator), Clara Ruiz-Ponte, Ceres Fernández-Rozadilla, Ma Magdalena Castro; Hospital Universitario Central de Asturias: Sabino Riestra (local coordinator), Luis Rodrigo; Hospital de Galdácano, Vizcaya: Javier Fernández (local coordinator), Jose Luis Cabriada; Fundación Hospital de Calahorra (La Rioja) La Rioja: Luis Carreño (local coordinator), Susana Oquiñena, Federico Bolado; Hospital Royo Villanova, Zaragoza: Elena Peña (local coordinator), José Manuel Blas, Gloria Ceña, Juan José Sebastián; Hospital Universitario Reina Sofía, Córdoba: Antonio Naranjo (local coordinator)., The common −652 6N del variant in the CASP8 promoter (rs3834129) has been described as a putative low-penetrance risk factor for different cancer types. In particular, some studies suggested that the deleted allele (del) was inversely associated with CRC risk while other analyses failed to confirm this. Hence, to better understand the role of this variant in the risk of developing CRC, we performed a multi-centric case-control study. In the study, the variant −652 6N del was genotyped in a total of 6,733 CRC cases and 7,576 controls recruited by six different centers located in Spain, Italy, USA, England, Czech Republic and the Netherlands collaborating to the international consortium COGENT (COlorectal cancer GENeTics). Our analysis indicated that rs3834129 was not associated with CRC risk in the full data set. However, the del allele was under-represented in one set of cases with a family history of CRC (per allele model OR = 0.79, 95% CI = 0.69–0.90) suggesting this allele might be a protective factor versus familial CRC. Since this multi-centric case-control study was performed on a very large sample size, it provided robust clarification of the effect of rs3834129 on the risk of developing CRC in Caucasians., For all cohorts: This work was supported by COST Action BM1206. Spanish cohort: SCB is supported by a contract from the Fondo de Investigación Sanitaria (CP 03-0070 to SCB). Networked Biomedical Research Centre for Hepatic and Digestive Diseases and Centro de Investigación Biomédica en Red de Enfermedades Raras are funded by the Instituto de Salud Carlos III. This work was supported by grants from the Fondo de Investigación Sanitaria/FEDER (08/0024, 08/1276, PS09/02368, 11/00219, 11/00681), Instituto de Salud Carlos III (Acción Transversal de Cáncer), Xunta de Galicia (07PXIB9101209PR), Ministerio de Ciencia e Innovación (SAF2010-19273), Asociación Española contra el Cáncer (Fundación Científica y Junta de Barcelona), Fundació Olga Torres (SCB and CRP), FP7 CHIBCHA Consortium (SCB and A. Carracedo). American cohort: Kentucky Colon Cancer Genetic Epidemiology Study is supported by National Institutes of Health grant R01CA136726 to LL. English cohort: Core funding to the Wellcome Trust Centre for Human Genetics was provided by the Wellcome Trust (090532/Z/09/Z). Czech cohort: Grant agency of the Czech Republic (GACR) [CZ:GACR:GA P304/10/1286 and P304/12/1585] and by Prvouk-P27/LF1/1 from Ministry of Education, Youth and Sport, Czech Republic (First Medical Faculty, Charles University, Prague, Czech Republic as a recipient). Dutch cohort: Dutch Cancer Society, grant KWF-UL-2010-4656.